Bone Marrow Transplantation Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.
General Pathology Department, School of Dentistry, University of São Paulo, 2227 Cidade Universitária, São Paulo, 05508-000, Brazil.
Support Care Cancer. 2020 Mar;28(3):1277-1287. doi: 10.1007/s00520-019-04922-x. Epub 2019 Jun 24.
The aim of this study was to characterize the taste changes and taste bud atrophy observed in the period of neutropenia of HCT and to determine the influence of transplantation toxicity on these changes.
Autologous and allogeneic HCT patients (n = 51) were selected to perform taste acuity tests prior to conditioning (T0) and during neutropenia (T1). The frequency and time duration of oral mucositis, presence of tongue depapillation, and salivary flow rate were also evaluated. Quality of life was assessed using specific questionnaires.
We observed a significant increase in hypogeusia (66.6%, p = 0.001) and dysgeusia (21.4%, p = 0.013) at T1, compared with T0. Bitter taste was the most altered, mainly when the patient underwent conditioning with melphalan (OR = 4.47, p = 0.049). Prolonged oral mucositis (≥ 8 days) (OR = 5.62, p = 0.039) and autologous transplantation (OR = 4.08, p = 0.033) were predictive factors for tongue depapillation. Changes in sour taste (OR = 10.70, p = 0.045) and reduced salivary flow (OR = 21.00, p = 0.013) were associated to body weight loss at T1. Taste changes significantly reduced the quality of life at T1, compared with T0.
Frequency of hypogeusia was high in the neutropenia period of the HCT. None of the taste changes was determined by oral mucositis, tongue depapillation, or reduced salivary flow, but melphalan conditioning reduced the bitter taste sensation. Loss of body weight and poor quality of life were associated with taste changes and reduced salivary flow. Further studies are necessary to elucidate this association and the risk factors for taste changes in HCT.
本研究旨在描述造血干细胞移植(HCT)中性粒细胞减少期间观察到的味觉变化和味蕾萎缩,并确定移植毒性对这些变化的影响。
选择 51 例自体和同种异体 HCT 患者,在预处理前(T0)和中性粒细胞减少期间(T1)进行味觉敏锐度测试。还评估了口腔黏膜炎的频率和持续时间、舌乳头萎缩的存在以及唾液流率。使用特定问卷评估生活质量。
与 T0 相比,T1 时我们观察到味觉减退(66.6%,p=0.001)和味觉障碍(21.4%,p=0.013)显著增加。苦味是最受影响的味觉,主要发生在接受马法兰预处理的患者中(OR=4.47,p=0.049)。口腔黏膜炎持续时间延长(≥8 天)(OR=5.62,p=0.039)和自体移植(OR=4.08,p=0.033)是舌乳头萎缩的预测因素。酸味变化(OR=10.70,p=0.045)和唾液流率降低(OR=21.00,p=0.013)与 T1 时体重减轻相关。与 T0 相比,T1 时味觉变化显著降低了生活质量。
HCT 中性粒细胞减少期间味觉减退的频率较高。味觉变化与口腔黏膜炎、舌乳头萎缩或唾液流率降低无关,但马法兰预处理降低了苦味感觉。体重减轻和生活质量差与味觉变化和唾液流率降低相关。需要进一步研究阐明 HCT 中味觉变化的这种关联和危险因素。